4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0002007730-26-000002
SVP, Chief Accounting Officer sold 49,524 shares at $1.39 ($68,838)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Malabre Richard C · SVP, Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-02 | Sale : show line 1 in the form 10b5-1 | −36,142 | $1.39 | $50,237 | 312,772 | D |
| 2026-02-02 | Sale : show line 2 in the form 10b5-1 | −13,382 | $1.39 | $18,601 | 299,390 | D |
| Open-market sales · 49,524 sh · avg $1.39 · $68,838 | ||||||
Loading xslF345X05/primarydocument.xml…